Yahoo Finance

Viral Vector Collaboration and Licensing Agreements Analysis Report 2024 with Directory of 396 Deals Signed Since 2016 by Company A-Z, Financial terms, Deal Type and Therapy Focus

Dublin, Jan. 03, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a ...
Yahoo Finance

Viral Vector Collaboration, R&D, and Licensing Deals Trends Report 2024 with Directory of 396 Agreements Signed Since 2016

Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Viral Vector Collaboration and ...
Yahoo Finance

Viral Vector Collaboration and Licensing Agreements Analysis Report and Directory 2016-2025: Access to Confidential Contract Documents for In-Depth Due Diligence and Benchmarking

Dublin, May 23, 2025 (GLOBE NEWSWIRE) -- The "Viral Vector Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...
PharmiWeb

ViroCell Biologics and AvenCell Therapeutics announce retroviral vector manufacturing collaboration to accelerate development of novel allogeneic CAR-T therapies for blood cancers

ViroCell Biologics and AvenCell Therapeutics announce retroviral vector manufacturing collaboration to accelerate development of novel allogeneic CAR-T therapies for blood cancers AvenCell selected ...
Finanznachrichten

ViroCell Biologics and AvenCell Therapeutics Announce Retroviral Vector Manufacturing Collaboration to Accelerate Development of Novel Allogeneic CAR-T Therapies for Blood Cancers

AvenCell selected ViroCell for retroviral vector CDMO services to drive its pipeline of innovative allogeneic CAR T-cell therapies, based on ViroCell's deep expertise and track record. ViroCell ...